What's in Mounjaro, and how does each part work?

Why the dual-receptor design is what makes tirzepatide different

GLP-1 receptor agonists have been used in medicine for over a decade. What sets tirzepatide apart is that it also activates the GIP receptor (glucose-dependent insulinotropic polypeptide) a second gut hormone that plays its own role in appetite regulation, fat storage and insulin sensitivity. The two receptors work through overlapping but distinct pathways. By engaging both at once, tirzepatide slows gastric emptying more consistently, signals fullness to the brain more persistently, and has effects on energy metabolism that a single-receptor drug cannot replicate in quite the same way. The GIP component in Mounjaro is the subject of ongoing research, but the clinical outcome of combining both pathways is already well documented.

This is not simply a marketing distinction. In the SURMOUNT-1 trial (2,539 adults with obesity, randomised over 72 weeks) participants on the 15 mg dose achieved an average body-weight reduction of around 20–21%, findings published in the New England Journal of Medicine. Those results are attributed, at least in part, to the dual mechanism. Understanding what is in Mounjaro helps explain why its evidence profile looks the way it does.

If you want a detailed look at how tirzepatide sits within the broader range of weight-loss options, the tirzepatide overview covers the mechanism alongside the licensed indications.

What the inactive ingredients actually do inside the pen

Pharmaceutical formulations are rarely just active ingredient plus water, and Mounjaro is no different. Sodium phosphate dibasic heptahydrate acts as a buffer, keeping the solution at the specific pH needed for tirzepatide to remain chemically stable. Sodium chloride maintains the tonicity of the solution, in plain terms, it helps the injection fluid behave safely when it meets the body's own fluid environment. Hydrochloric acid and sodium hydroxide are used during manufacture to fine-tune the pH to the target range; traces may remain but at levels that are clinically insignificant. Water for injection is the carrier solvent, manufactured to pharmacopoeial standards, free of pyrogens and contaminants in a way that tap water and saline drips are not.

The absence of preservatives is practically important. It is why the pen must be stored in a refrigerator between 2°C and 8°C, and why there is a limited window for use at room temperature once removed. The exact duration of that window is specified in the Mounjaro SmPC on the eMC; always check the leaflet in your pack rather than relying on a figure quoted online, because the permitted window can differ depending on storage conditions and pen strength. Worth checking, it matters more than people expect.

The KwikPen itself contributes no active substance. The needle gauge and pen mechanism are designed for subcutaneous delivery into the abdomen, thigh, or upper arm, with injection sites rotated week to week. Questions about injection technique are best directed to your prescribing team.

Mounjaro's UK licence and what the NICE evidence review found

Tirzepatide received its UK weight-management licence for adults with a BMI of 30 or above, or a BMI of 27 or above alongside at least one weight-related condition such as high blood pressure, type 2 diabetes, or dyslipidaemia. NICE appraised it in Technology Appraisal TA1026, published December 2024, recommending tirzepatide for use within the NHS for adults with a BMI of at least 35 and one or more weight-related comorbidities, with lower BMI thresholds for people from certain ethnic backgrounds under UK guidance. That appraisal drew on the full SURMOUNT clinical programme, covering thousands of adults across different populations.

The NHS rollout is phased, meaning many people who meet the private licensed criteria do not yet qualify for an NHS prescription. Private treatment through a regulated pharmacy remains the route for those people, provided clinical suitability is confirmed. Understanding what Mounjaro is and what it contains is a reasonable first step before deciding whether to pursue a consultation. The alternatives to Mounjaro page covers the other licensed options if tirzepatide turns out not to be right for you.

Cost is often the next question after composition. A factual overview of how Mounjaro is priced in the UK private market explains what has changed since Eli Lilly's 2025 list-price revision and what a legitimate private price should include. Separate from cost, when you take Mounjaro each week is worth thinking about early, consistency matters, and some people find aligning the injection day with a routine (not a Monday if you often have a busy start to the week, not just before a bank holiday) makes adherence easier.

What Mounjaro does not contain, and why that question matters

A question our prescribers hear regularly is whether Mounjaro contains anything hormonal, oestrogen, testosterone, thyroid hormone. It does not. Tirzepatide is a synthetic peptide that mimics endogenous gut hormones; it is not a steroid, not a thyroid hormone, and not classified as a controlled drug. It does not contain insulin, which matters because counterfeit pens seized by the MHRA have been found to contain insulin, posing serious risk to people who are not diabetic. Buying from a pharmacy you cannot verify on the GPhC register carries exactly that danger.

Mounjaro is also gluten-free and does not contain lactose, making allergen concerns about the excipients uncommon, though anyone with a known sensitivity should check the full SmPC. The formulation does not interact with alcohol in the way some medicines do, but alcohol can worsen the gastrointestinal side effects (nausea, reflux, indigestion) that are most common in the early weeks of treatment.

If you have clinical questions after reading what tirzepatide contains, the right place to take them is a prescriber, not a forum. The weight-loss treatments page sets out how to start a consultation with our clinical team, who review each case personally. Our clinical team is available to discuss suitability seven days a week.